What is the dosage form and frequency of Brexanolone?

Brexanolone is administered as an intravenous (IV) continuous infusion over 60 hours for the treatment of postpartum depression. This specific route and method of administration are essential because brexanolone requires a controlled environment in a healthcare setting to monitor the patient closely, due to potential side effects and the need for careful titration of the dosage.

Continuous IV infusion allows for a steady release of the medication into the bloodstream, helping to maintain therapeutic levels without the peaks and troughs that might occur with bolus dosing forms. The 60-hour duration is critical, as it aligns with the typical requirement to achieve the desired therapeutic effects for women experiencing severe postpartum depression. This unique dosing regimen differentiates brexanolone from more traditional oral or injection protocols, making it specifically suited for this condition's treatment.